{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-015734","form_type":"8-K","ticker":"HIND","cik":"0001427570","company_name":"Vyome Holdings, Inc","filed_at":"2024-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.426554+00:00","generated_at":"2026-05-30T00:24:05.187971+00:00","sec_items":["2.02","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"ReShape reports Q3 rev $2.3M (+6.4% YoY); merger with Vyome, asset sale to Biorad for $5.16M","bullets":["Q3 revenue $2.3M, up 6.4% YoY and 16.6% sequentially; gross margin 62.8%.","Operating expenses down 40.6% in first 9 months of 2024 vs 2023.","Merger with Vyome: ReShape stockholders to own ~11.1% of combined company.","Asset sale to Biorad for $5.16M cash; includes Lap-Band, Obalon, DBSN systems.","Received Health Canada approval for Lap-Band 2.0 FLEX and $241K NIH grant."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-015734","json":"https://secwatch.observer/filing/0001558370-24-015734.json","markdown":"https://secwatch.observer/filing/0001558370-24-015734.md","text":"https://secwatch.observer/filing/0001558370-24-015734.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427570/000155837024015734/0001558370-24-015734-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427570/000155837024015734/rsls-20241114x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:24:05.187971+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}